Pairwise
PrivateLast Round
Series C
Sep 17, 2024
Total Funding Raised
$155M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pairwise is an agricultural technology company that uses CRISPR gene-editing technology to develop new varieties of fruits and vegetables.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, D2C Brands
Business Model
B2B
Customer Profile
Data as a Service, Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pairwise Comparables
Compare Pairwise with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ohalo | 82% | |
| Phytoform Labs | 79% | |
| Hudson River Biotechnology | 79% |
Pairwise Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Series B | Feb 3, 2021 | ||||
| Series A | Mar 20, 2018 |
Pairwise Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C, Series A, Series B |
| Temasek | Series B |
| Corteva Catalyst | Series C |
| Aliment Capital | Series C, Series B |
| Leaps by Bayer | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 35% MoM, reaching 14.4K.
- Apr 22, 2026
Integrating precision-editing technology with AI-based trait discovery.
Recent news
Latest coverage and updates
- is_developingAug 1, 2026
Pairwise is planning to develop more compact yam varieties for use in African production systems.
Pairwise Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pairwise's valuation, stock price, and market status.
Is Pairwise a public or private company?
Pairwise is a private company.
What is the current stock price of Pairwise?
Pairwise is a private company with no public stock price. No recent secondary market data is available.
How much is Pairwise worth (valuation)?
Valuation information for Pairwise is not publicly available.
Can I buy Pairwise stock?
Pairwise shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pairwise's last funding round?
Pairwise's most recent funding round was Series C on September 17, 2024.
Who are the main investors in Pairwise?
Key investors in Pairwise include Deerfield Management, Aliment Capital, Leaps by Bayer.
Will Pairwise IPO soon?
No public IPO plans have been announced for Pairwise.
How can I track Pairwise secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pairwise's secondary market activity and sign up for updates.